Compare DSWL & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DSWL | COCH |
|---|---|---|
| Founded | 1987 | 1995 |
| Country | Macau | United States |
| Employees | 854 | N/A |
| Industry | Plastic Products | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.4M | 49.9M |
| IPO Year | 2000 | 2021 |
| Metric | DSWL | COCH |
|---|---|---|
| Price | $3.04 | $3.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.17 |
| AVG Volume (30 Days) | 7.8K | ★ 65.2K |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | ★ 6.56% | N/A |
| EPS Growth | N/A | ★ 17.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $241,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $17.14 |
| P/E Ratio | $4.59 | ★ N/A |
| Revenue Growth | N/A | ★ 7.11 |
| 52 Week Low | $2.84 | $0.36 |
| 52 Week High | $4.06 | $0.95 |
| Indicator | DSWL | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 49.84 | 45.78 |
| Support Level | $2.96 | $0.63 |
| Resistance Level | $3.32 | $0.74 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 29.41 | 50.19 |
Deswell Industries Inc comprise the manufacturing and sales of injection-molded plastic parts and components and electronic products assembling. The manufacturing activities are subcontracted to operating in the Macao Special Administrative Region (Macao) of the PRC. It produce a wide variety of plastic parts and components that are used in the manufacture of consumer and industrial products, using different plastic injection technologies, such as film injection, integrated injection and insert injection. It has two segments: plastic injection molding and electronic products assembling. It has generates majority of profit from Electronic Segment. It has presence in China, United States, Europe, Hong Kong, United Kingdom, Canada, and Others of which majority of sales is from China.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.